A combined pharmacokinetic-pharmacodynamic study of Org NC 45 was performed in six patients undergoing elective oro-facial surgery. The pharmacokinetics could be described using a twocompartment open model with a distribution half-life of approximately 4 min and an elimination half-life of approximately 31 min. The pharmacokinetic parameters confirm earlier clinical findings that Org NC 45 has a more rapid onset and a shorter duration of action than pancuronium, and a faster recovery rate. When comparing the pharmacokinetic and pharmacodynamic parameters the biophase could be distinguished from both the central and the peripheral compartments. The mean steady-state plasma concentration producing a 50% block of the twitch response was 0.137 ug ml" 1 (range 0.118-0.176 ug ml' 1 ).
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(range 0.118-0.176 ug ml' 1 ).
Org NC 45 has been shown to be a short-acting non-depolarizing neuromuscular blocking drug with a wide margin of safety. It is virtually devoid of vagolytic activity in animals (Marshall et al., 1980) . Preliminary clinical trials showed it to act faster than pancuronium and to have a faster recovery rate. In order to establish dose regimes for bolus injections and constant infusion regimes we report here a combined pharmacokinetic and dynamic study performed in six patients undergoing oro-facial surgery. The pharmacokinetic study was based on a specific assay developed for Org NC 45 which excluded its hydrolysis or metabolic products (J. E. Paanakker and G. Van de Laar, in preparation) .
METHODS
Informed consent was obtained from the six patients undergoing facial or oral surgery who participated in the study. Details of the patients arid of the doses of Org NC 45 used are given in table I. One hour before surgery droperidol 5 mg i.m. and atropine 0.5 mg i.m. were given. Anaesthesia was induced with droperidol 15 mg i.v. or diazepam 10 mg i.v. with fentanyl 0.2 mg i.v. and either etomidate 18 mg i.v. or thiopentone 100 mg i.v. Anaesthesia was maintained using nitrous F. VAN oxide (66%) in oxygen supplemented with additional doses of droperidol and fentanyl. Four patients (A, D, F and G) were given suxamethonium to facilitate endotracheal intubation. Small stainless-steel needle electrodes were placed in the left forearm and the ulnar nerve was stimulated using a supramaximal voltage at 0.1 Hz (Grass S 48 stimulator and SIU 5 isolation unit). The evoked twitch contraction of the adductor pollicis muscle was recorded using a Statham VC3 Gold cell linear force transducer attached to a Brush Clevite recorder. The maximum effect of Org NC 45, the duration of action and the recovery rate were measured.
Org NC 45 was given initially as a rapid bolus injection of 0.089-0.12 mgkg" 1 via an antecubital vein in the right forearm. In four patients (A, F, G and H) a constant infusion of between 1.2 and 1.51 ugkg" 1 min" 1 was given via the same vein for periods of between 80 and 202 min.
Venous blood samples (8 ml) were taken at predetermined times from an indwelling catheter in another vein. These samples, mixed with citrate as an anticoagulant, were centrifuged immediately and the volume and pH measured immediately after centrifugation. The pH of the sample was adjusted to approximately 6 units using a sodium phosphate buffer to prevent the hydrolysis of Org NC 45 which occurs at physiological pH. The plasma concentrations of Org NC 45 were determined using a selective high performance liquid chromatographic (HPLC) assay which used ionpair extraction and straight-phase adsorption 
Pharmacokinetic and pharmacodynamic modelling
A linear two-compartment open model with injection into and elimination from the central compartment was used to describe the time-course of plasma concentrations of Org NC 45 following the bolus injection and the constant infusions (Hull, 1979) . The concentration of drug in the central compartment (C,) as a function of time is given by C, = /J o e-" + B 0 e-" Where a and /? are the rate constants for the distribution and elimination phases and A o and B o the extrapolated theoretical concentrations at zero time for the two phases.
From these "functional" parameters the following "model" parameters were calculated (Hull, 1979) : k l2 = the rate constant from the central to the peripheral compartment, k 21 = the rate constant from the peripheral to the central compartment, k l0 = the rate constant from the central compartment to the outside (the elimination constant), V l = the volume of the central compartment, V % = the steady-state volume of distribution.
For the subsequent modelling of the pharmacodynamic response, the two-compartment model was extended to include a hypothetical effect compartment (Sheiner et al., 1979) . Drug is tranferred to this effect compartment from the central compartment. The mathematical expression describing the neuromuscular blocking effect (E) is given by E = (* eo zy+c p »(5oy where k co = rate constant from the effect compartment to outside; C P "(50) = the plasma concentration at a steady state which produces 50% of the maximal effect; Z = a function of the pharmacokinetic parameters and time and y = a parameter for the sigmoid relationship between the effect and the drug concentration in the effect compartment.
The steady-state plasma concentration eliciting any value of the effect E between zero and unity (maximal effect) (C P "(£)) can be calculated:
The curve-fitting and the solution of the necessary equations were performed using non-linear least square regression analyses by a Fortran IV computer program based on a random search algorithm.
RESULTS
Following the administration of an i.v. bolus complete neuromuscular block was produced after an average onset time of 2.7 min. The plasma concentrations showed a rapid initial decline followed by a more gradual decline ( fig. 1 ). In four of the patients a continuous infusion was started during the recovery phase from the bolus dose. After stopping the infusion there was a rapid recovery of normal neuromuscular transmission ( fig. 2) . The constant infusions produced increases in the plasma concentrations of the drug towards plateau values; following the infusion the plasma concentrations decayed in a bi-exponential fashion ( fig. 2) . Details of the onset of and recovery from the neuromuscular block are given in table II. Of the six patients studied two could not be included in the analysis; patient A because it was not possible to use the model to combine the pharmacokinetic and pharmacodynamic data and patient G because the infusion rate was not constant (varying between 1.0 and 2.0 ugkg" 1 min" 1 ). The kinetic parameters for the remaining four patients are given in table III. The central volume had a mean value of approximately 77 ml kg"'; in physiological terms such a volume is larger than the plasma volume but less than the extracellular fluid volume. The steady-state distribution volume had a mean value of 179 ml kg"' which is almost equivalent to the extracellular fluid volume. The disappearance of drug in the twocompartment model is characterized by two components. The rapid component (the distribution phase) had a mean half-life of 4 min and the slow component (the elimination phase) had a mean half-life of 31 min. Table III also gives the kinetic rate constants.
The dynamic parameters k co , y and C P "(50) are shown in table IV. The rate constant of elimination of the drug from the effect compartment (k t0 ) had a mean value of 0.27 min"' (that is a half-life of 2.6 min) and a significantly larger value than that for the transfer of the drug from the peripheral to the central compartment (k 21 = 0.076 min"'). The model used implies that the "effect" compartment can only be taken to be part of the peripheral compartment if these two constants are not significantly different. The finding that k eo is not very large compared with any of the other rate constants also implies that the effect compartment is not a component of the central compartment.
The mean steady-state plasma concentration giving a 50% depression of the twitch force was 0.137 ugml" 1 and that giving a 90% block was 0.206 ng ml" 1 . Table IV gives the individual estimations. A comparison of the kinetic and dynamic parameters shows that the biophase can be clearly distinguished from both the central and peripheral compartments. Similar results have been described for tubocurarine (Sheiner et al., 1979) .
Only in steady-state conditions is it possible to relate the effect produced to the concentration of drug in the central compartment, for in these conditions there is a kinetic equilibrium between all the body compartments. The sigmoidicity of the dose-response curve in the effect compartment for Org NC 45 (y = 5.7) is different from that of tubocurarine (>• = 2.53) (Sheiner et al., 1979) . It is possible to interpret this parameter as the mean number of molecules of the drug that act on one receptor entity to produce the effect. However, this interpretation of receptor occupancy theory does not explain all the pharmacodynamic phenomena and it is safer to consider it as one useful parameter describing the pharmacodynamic effect which can be used to make predictions with kinetic and dynamic models.
The elimination half-life for pancuronium has been found to be 110 min (Miller et al., 1978) and 127 min (Somogyi, Triggs and Shanks, 1978) . The value for Org NC 45 (31 min) is much less and may explain the shorter duration of action and the more rapid rate of recovery from Org NC 45 when compared with pancuronium.
The combination of the kinetic and dynamic models described here should allow predictions to be made as to what are optimal dose regimes for use with multiple or single bolus doses and for continuous infusion regimes for Org NC 45.
RESUME
Une etude combinee phannacocinetique-pharmacodynamique d'Org NC 45 a etc faite sur six malades subissant une intervention oro-faciale a froid. La pharmacocinetique a pu etre dccrite grace a un modcle ouvert a deux compartiments, avec une demi-vie de repartition d'environ 4 mo et une demi-vie d'elimination d'environ 31 mn. Les parametres de la pharmacocinetique connrment les observations cliniqucs anterieures, a savoir qu'Org NC 45 a un debut d'action plus rapide et une duree d'action plus courte que le pancuronium de meme qu'un taux de recuperation plus rapide. Lorsqu'on a compare les parametres de pharmacocinetique et de pharmacodynamique on a pu distinguer la biophasc du compartiment central et celle du compartiment periphcriquc. L'cquilibre cinetique moyen de la concentration Hnn< le plasma produisant un blocage de 50% dc la reaction a la crispation a ete de 0,137 ug ml"' (plage de 0,118-0,176 ug ml" 1 ). Zuckreaktion-Blockierung betrug 0,137 ug ml" 1 (Bereich 0,118-0,176 ug ml" 1 ).
FARMACOCINETICAS V FARMACODINAMICAS DEL ORG NC 45 EN EL HOMBRE

SUMARIO
Se efectuo un estudio farmacocinetico-farmacodinamico combinado del Org NC 45 en 6 pacientcs en proceso electivo de cirugia orofacial. Las farmacocineticas pudieron describirse usando un modelo abierto de 2 compartimentos, con un periodo de media vida de distribucion de aproximadamente 4 minutos y un periodo de media vida de elimination de 31 minutos, aproximadamente. Los parametros farmacocineticos confirmaron los resultados clinicos anteriores dc que el Org NC 45 posee una accion mas rapida y dc mas corta duration que cl pancuronium, asi como un regimen de recuperation mas rapido. Al comparar los parametros farmacocincticos y los farmacodinamicos, pudo distinguirse la biofase del compartimento central y del periferico. La concentration media y constante de plasma para producir un 50% de bloqueo de la respuesta de suspension fue de 0,137 ug ml" 1 (gama de 0,118-0,176 ug ml"').
